Abstract 3222: Assessment of change in HER2 status and its outcomes after neoadjuvant chemotherapy with trastuzumab and/or pertuzumab in early-stage breast cancer patients

Authors: Manasi M. Godbole, Kathren Shango, Matthew Meranda, Carl P. Wilson, Vrushali Dabak

Published: 2023-04-04

DOI: 10.1158/1538-7445.am2023-3222

Source: Full article